TABLE 2.
Characteristics and prevalence of mid‐term (more than 6 months after discharge) clinical sequelae of the COVID‐19 survivors
| Clinical sequelae | COVID‐19 survivors (n = 715) |
|---|---|
| General symptoms, n (%) | 159 (22.2%) |
| Fatigue | 137 (19.2%) |
| Others | 29 (4.1%) |
| Respiratory symptoms, n (%) | 162 (22.7%) |
| Cough | 82 (11.5%) |
| Sputum | 35 (4.9%) |
| Exertional or resting dyspnea | 85 (11.9%) |
| Chest tightness | 49 (6.9%) |
| Cardiovascular symptoms, n (%) | 36 (5.0%) |
| Palpitation | 27 (3.8%) |
| Orthopnea | 4 (0.6%) |
| Lower limb edema | 7 (1.0%) |
Note: Data are n (%), where n is the total number of patients with available data.
Abbreviation: COVID‐19, coronavirus disease 2019.